Literature DB >> 2748831

Whole-body lymphangioscintigraphy: preferred method for initial assessment of the peripheral lymphatic system.

G C McNeill1, M H Witte, C L Witte, W H Williams, J N Hall, D D Patton, G D Pond, J M Woolfenden.   

Abstract

In 20 patients with congenital and acquired lymphedema in either upper or lower extremities and in four patients without extremity edema, human serum albumin labeled with technetium-99m was injected intradermally into a digital web space of the hand or foot. With a digital gamma camera that permitted a "sweep" of the torso, serial extremity and whole-body lymphagioscintigraphy (LAS) of the peripheral lymphatic system was performed. In 11 patients with acquired lymphedema, a well-defined obstructive pattern was seen, characterized by discrete peripheral lymphatic trunks, delayed or absent depiction of regional nodes, and delayed but extensive soft-tissue tracer extravasation. Five of nine patients with congenital lymphedema showed hypoplasia characterized by poorly defined lymphatic trunks, delayed depiction of regional nodes, and early and extensive extravasation of tracer. The other four patients showed aplasia, with absence of trunks, no depiction of nodes, and little or no tracer extravasation. LAS is technically simple to perform and requires no special training. Radiation exposure is minuscule, and the procedure is safe and without apparent side effects. For these reasons, whole-body LAS should be the preferred method for the initial assessment of congenital or acquired lymphedema.

Entities:  

Mesh:

Year:  1989        PMID: 2748831     DOI: 10.1148/radiology.172.2.2748831

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  13 in total

1.  Label-free optical lymphangiography: development of an automatic segmentation method applied to optical coherence tomography to visualize lymphatic vessels using Hessian filters.

Authors:  Siavash Yousefi; Jia Qin; Zhongwei Zhi; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2013-08       Impact factor: 3.170

2.  Medical ignorance, AIDS-Kaposi's sarcoma complex, and the lymphatic system.

Authors:  M H Witte; C L Witte; D L Way
Journal:  West J Med       Date:  1990-07

3.  Label-free optical imaging of lymphatic vessels within tissue beds in vivo.

Authors:  Siavash Yousefi; Zhongwei Zhi; Ruikang K Wang
Journal:  IEEE J Sel Top Quantum Electron       Date:  2014 Mar-Apr       Impact factor: 4.544

Review 4.  New horizons for imaging lymphatic function.

Authors:  Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

5.  Ultrasonographic findings and the clinical results of treatment for lymphedema.

Authors:  Kiyoaki Niimi; Masafumi Hirai; Hirohide Iwata; Keiko Miyazaki
Journal:  Ann Vasc Dis       Date:  2014-12-25

6.  Primary lymphedema tarda in an 88-year-old African-American male.

Authors:  Ahmed Faraz Aslam; Ahmad Kamal Aslam; Muhammad Umair R Qamar; Robert Levey
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 7.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

Review 8.  Lung disease induced by drug addiction.

Authors:  M K Benson; A M Bentley
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

Review 9.  Lymphatic imaging in humans with near-infrared fluorescence.

Authors:  John C Rasmussen; I-Chih Tan; Milton V Marshall; Caroline E Fife; Eva M Sevick-Muraca
Journal:  Curr Opin Biotechnol       Date:  2009-02-23       Impact factor: 9.740

10.  Finding an optimal method for imaging lymphatic vessels of the upper limb.

Authors:  Susan O'Mahony; Sarah L Rose; Alison J Chilvers; James R Ballinger; Chandra K Solanki; Robert W Barber; Peter S Mortimer; Arnie D Purushotham; A Michael Peters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.